Canopy Growth Corporation “celebrates” the German government’s final approval legalizing cannabis. “In addition to the cultural significance of Germany’s cannabis legalization progress, these changes present a unique opportunity for Canopy Growth to expand its commercial presence in the country through the German-based and world renowned Storz & Bickel vaporizer brand, as well as the Company’s medical cannabis product offerings through Canopy Medical which collectively position Canopy Growth as a top three player in the German cannabis industry,” the company said in a statement. “This legislation represents a very important and long-overdue step to end the criminalization of cannabis in Germany and sets an important example for the whole of Europe,” said Jurgen Bickel, Managing Director of Storz & Bickel GmbH.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGC: